ZFYVE26 Gene SPG15 NGS Genetic Test
Short Name: ZFYVE26 SPG15 NGS
Also known as: SPG15 Genetic Test, ZFYVE26 Gene Sequencing, Hereditary Spastic Paraplegia Type 15 NGS Test
ZFYVE26 Gene SPG15 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are typically available within 3 to 4 weeks after the sample is received at the laboratory.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last reviewed: September 7, 2026
Overview
The purpose of the ZFYVE26 Gene SPG15 NGS Genetic Test is to confirm or rule out a clinical diagnosis of SPG15 by identifying disease-causing mutations in the ZFYVE26 gene. It helps in differentiating SPG15 from other forms of hereditary spastic paraplegia and supports informed treatment and reproductive decisions.
- Test Code
- 4521
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- Results are typically available within 3 to 4 weeks after the sample is received at the laboratory.
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS)
Sample Collection
A genetic counseling session is required prior to sample collection to document the clinical history and draw a pedigree chart of affected family members. No fasting is required for this test.
Method: Venipuncture or FTA card blood spot
Laboratory Analysis
During sample collection, a healthcare professional will draw a peripheral blood sample from the arm or obtain a few drops of blood on an FTA card for the test.
Report Delivery
After sample collection, the patient can resume normal activities without any restrictions. The sample is securely transported to the laboratory for analysis.
Timeline: Results are typically available within 3 to 4 weeks after the sample is received at the laboratory.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of the ZFYVE26 Gene SPG15 NGS Genetic Test is to confirm or rule out a clinical diagnosis of SPG15 by identifying disease-causing mutations in the ZFYVE26 gene. It helps in differentiating SPG15 from other forms of hereditary spastic paraplegia and supports informed treatment and reproductive decisions.
How to Prepare
- Please bring all relevant medical records, neuroimaging reports, and family history information for the genetic counseling session
- Ensure the FTA card is properly labeled with the patient's name, date, and time of collection
- For blood samples, use an EDTA vacutainer to avoid clotting
- Avoid sending samples that are hemolyzed or over-filled
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"Genetic testing for SPG15 not only confirms the diagnosis but also enables carrier testing and reproductive planning for affected families. I recommend NGS-based analysis of ZFYVE26 for patients presenting with early-onset progressive spastic paraplegia."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed or clotted blood sample
- Insufficient sample volume for DNA extraction
- Improperly labeled sample (no identifier)
- Incorrect sample container (e.g., serum tube instead of EDTA)
Understanding Your Results
Pathogenic or Likely Pathogenic Variant Detected
Confirms the diagnosis of ZFYVE26-associated SPG15. Genetic counseling is strongly recommended to discuss management and inheritance risks.
Negative (No Pathogenic Variant Detected)
No disease-causing mutation was identified in the ZFYVE26 gene. Other genetic and non-genetic causes should be considered.
Variant of Uncertain Significance (VUS)
A genetic change was found, but its clinical significance is currently unknown. Additional testing of family members may help clarify its role.
If the test result is positive, please consult a neurologist and a clinical geneticist to discuss personalized management, surveillance, and family planning options. For a VUS result, let your doctor know to plan follow-up family testing and potential functional studies.
Limitations
- ⚠This test analyses the ZFYVE26 gene only and will not detect mutations in other genes associated with hereditary spastic paraplegia
- ⚠Large genomic rearrangements, deep intronic mutations, or regulatory region variants may not be identified by standard NGS
- ⚠A negative result does not entirely exclude the possibility of SPG15, especially if sequencing coverage is incomplete or variant classification is uncertain
- ⚠The clinical significance of variants of unknown significance may require further family studies and functional analysis
Risks & Considerations
- ●No significant risks are associated with routine blood sampling, but mild bruising or bleeding may occur at the puncture site.
- ●Genetic testing may reveal unexpected risk information for family members; this may pose psychological or social implications.
- ●There is a possibility of discovering variants of uncertain significance which require further evaluation.
Interfering Factors
- ●Sample degradation due to prolonged storage or high temperature
- ●Presence of maternal cell contamination in fetal samples
- ●Conflicting variants in pseudogenes or homologous regions
- ●Incomplete clinical history leading to misinterpretation of variant significance
Frequently Asked Questions
What is SPG15?
What is the cost of the ZFYVE26 Gene SPG15 NGS Genetic Test?
What sample is required for this test?
Do I need to fast before the test?
How long does it take to get the test results?
Is home sample collection available?
Which cities are covered for home sample collection?
What technology is used for testing?
Does this test detect all types of hereditary spastic paraplegia?
Why is genetic counseling required before the test?
Will I receive raw sequencing data along with the report?
What does a negative result mean?
Related Tests
Angelman Syndrome Test
₹10,000Duchenne / Becker Muscular Dystrophy (DMD / BMD) Gene Mutation Test
₹14,000Episodic Ataxia Type 1 Hotspot Test
₹11,500Episodic Ataxia Comprehensive Profile Hotspot Test
₹16,000Megalencephalic Leukoencephalopathy with Subcortical Cysts Van Der Knaap and Nalband MLC Gene Hotspot Mutation Test
₹7,500Analyzer 18 SMA 18 Test Panel
₹1,755Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.
